Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 6Thoracic 3Dermatologic 1

Conditions

Melanoma 38Carcinoma, Renal Cell 12Carcinoma, Non-Small-Cell Lung 12Squamous Cell Carcinoma of Head and Neck 8Head and Neck Neoplasms 8Carcinoma, Merkel Cell 8Uterine Cervical Neoplasms 7Stomach Neoplasms 7Colorectal Neoplasms 6Carcinoma, Transitional Cell 6Carcinoma, Hepatocellular 6Small Cell Lung Carcinoma 5Neoplasms 5Kidney Neoplasms 5Urinary Bladder Neoplasms 4Triple Negative Breast Neoplasms 4Esophageal Neoplasms 3Breast Neoplasms 3Urogenital Neoplasms 2Skin Neoplasms 2Sarcoma 2Pancreatic Neoplasms 2Neoplasms by Histologic Type 2Microsatellite Instability 2Mesothelioma, Malignant 2Mesothelioma 2Lymphoma 2Lung Neoplasms 2Gastrointestinal Neoplasms 2Carcinoma, Squamous Cell 2

Interventions

Radiosurgery 22Ipilimumab 17Nivolumab 16pembrolizumab 11Temozolomide 9encorafenib 8dabrafenib 8binimetinib 8Magnetic Resonance Spectroscopy 6trametinib 5Bevacizumab 5CTLA-4 Antigen 4cobimetinib 3Thalidomide 3Radiotherapy 3Paclitaxel 3entrectinib 2cediranib 2Vemurafenib 2Spermine Synthase 2Specimen Handling 2Radiation 2Pemetrexed 2Opdualag 2Drug Therapy 2Carboplatin 22,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 214-(ethylamino)-8,9,16-trihydroxy-3,4-dimethyl-3,4,9,19-tetrahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione 2130-nm albumin-bound paclitaxel 2relatlimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × atezolizumab × Dermatologic × Clear all
NCT03175432 2026-04-15

Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
29 enrolled
CNSDermatologic

Brain Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡